Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2025 American Chemical Society
April 3, 2023 Cover
Volume 101, Issue 11
Chemical companies want to capture carbon, but local communities don’t want it under their lake
Volume 101 |
Issue 11
Potential thermochemistry replacements starred at Paris conference
Start-ups touted technologies that could change the way we process chemicals
Peptide nucleic acids progress for gene editing and antisense drugs
These lab-made molecules can bind to genes more strongly than DNA and RNA do, making them promising drug candidates and genetic tools
-
C&EN talks with Ziba Ardalan, art curator
The Iranian art-world leader discusses how her science background shapes her creative work
-
Small molecule treats multiple sclerosis in rodents
Compound inhibits receptor associated with signaling in certain cells in the central nervous system
-
ACS Spring 2023 in Indianapolis
Lots to celebrate at ACS’s fourth hybrid meeting
ADVERTISEMENT
Science Concentrates
ACS Spring 2023 in Indianapolis
Lots to celebrate at ACS’s fourth hybrid meeting
